Today, after receiving a gene therapy developed at the University of California San Diego, Natalie is thriving at 34 years ...

The Australian research, which aims to help people with motor neuron disease keep moving, is now testing AI to personalise assistance.

An A.I.-powered avatar platform aims to restore speech, identity and dignity for people living with ALS and paralysis.

More than 250 community members gathered Saturday morning at Miller/Knox Regional Shoreline in Richmond for the 26th Annual ...

In 2025, Hollywood star Eric Dane shared with the world that he had been diagnosed with a serious disorder that has left him ...

The Muscular Dystrophy Association (MDA) recognizes the U.S. Food and Drug Administration (FDA) approval of Amgen’s UPLIZNA ® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis ...

Columnist Juliet Taylor and her late husband, Jeff, fought hard for precious holiday moments after he was diagnosed with ALS.

The Muscular Dystrophy Association (MDA) recognizes the U.S. Food and Drug Administration (FDA) approval of Amgen's UPLIZNA(R) (inebilizumab-cdon) for the treatment of generalized myasthenia gravis ...

In addition to ALS, pridopidine is in late-stage clinical development for HD, with Prilenia and Ferrer planning to initiate a confirmatory study in HD designed to confirm pridopidine's effects and ...

Highlights: FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol This marks the official entry of NUZ-001 as Regimen I in the HEALEY ALS ...

A local man is using what time he has left to to raise awareness about the financial and emotional toll A-L-S, also known as ...

Tech companies, a charity and academics have collaborated to create AI-powered avatars that are helping people with motor ...